日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Disabling PSGL-1 abrogates immune suppression and resistance to PD-1 blockade in pancreatic cancer

抑制PSGL-1可消除胰腺癌中的免疫抑制和对PD-1阻断疗法的耐药性

Hope, Jennifer L; Zhang, Yijuan; Hetrick, Hannah A F; Sanchez-Hernandez, Evelyn S; Silvestri, Beatrice; Smith, Brianna J; Nakil, Sanmati H; Roy, Sreeja; Lin, Michelle; Palete, Ashley B; Maganti, Swetha; Ling, Lily; Otero, Dennis C; Byrne, Katelyn T; Romano, Gabriele; Wang, Yu Xin; Commisso, Cosimo; Bradley, Linda M

PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion

PSGL-1减弱早期TCR信号传导,抑制CD8+ T细胞祖细胞分化,并导致CD8+ T细胞终末耗竭。

Jennifer L Hope ,Dennis C Otero ,Eun-Ah Bae ,Christopher J Stairiker ,Ashley B Palete ,Hannah A Faso ,Michelle Lin ,Monique L Henriquez ,Sreeja Roy ,Hyungseok Seo ,Xue Lei ,Eric S Wang ,Savio Chow ,Roberto Tinoco ,Gregory A Daniels ,Kevin Yip ,Alexandre Rosa Campos ,Jun Yin ,Peter D Adams ,Anjana Rao ,Linda M Bradley